Article Details
Retrieved on: 2018-02-22 04:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Their approach results in significant inhibition of tumor growth, even against cancers which do not respond to existing immunotherapies used in the clinic. In collaboration with <b>Insilico Medicine</b>, a Baltimore-based leader in artificial intelligence for drug discovery, the team reports their results this week in ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here